{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T17:59:37Z","timestamp":1790272777114,"version":"4.1.0"},"reference-count":142,"publisher":"Journal of Neurosurgery Publishing Group (JNSPG)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["FOC"],"published-print":{"date-parts":[[2017,4]]},"abstract":"<jats:p>Atherosclerotic disease of the cerebral vasculature is a major cause of stroke worldwide. Atherosclerosis that is refractory to best medical management may require revascularization. In these instances, endovascular treatment provides a popular and safe alternative to open surgical techniques. The authors provide an overview of stent technology in the treatment of ischemic stroke, discussing the major studies evaluating stenting for extracranial carotid artery, vertebral artery, and intracranial atherosclerotic disease. The authors describe the commonly used stents with respect to their individual characteristics and technical limitations. Current and future developments in stent technology are also discussed, with areas for further innovation and clinical research.<\/jats:p>","DOI":"10.3171\/2017.1.focus16507","type":"journal-article","created":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T03:44:48Z","timestamp":1491018288000},"page":"E11","source":"Crossref","is-referenced-by-count":18,"title":["Stent technology in ischemic stroke"],"prefix":"10.3171","volume":"42","author":[{"given":"Nam K.","family":"Yoon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Al-Wala","family":"Awad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Yashar S.","family":"Kalani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philipp","family":"Taussky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min S.","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1754","reference":[{"key":"b1-focus16507","series-title":"Am J Cardiol","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.1016\/j.amjcard.2005.11.034","article-title":"Comparison of sirolimus versus paclitaxel eluting stents for treatment of coronary in-stent restenosis","volume":"97","author":"Airoldi F,","year":"2006","unstructured":"Airoldi F, Briguori C, Iakovou I, Stankovic G, Biondi-Zoccai G, Carlino M, : Comparison of sirolimus versus paclitaxel eluting stents for treatment of coronary in-stent restenosis. Am J Cardiol 97:1182\u20131187, 20061661602310.1016\/j.amjcard.2005.11.034"},{"key":"b2-focus16507","series-title":"J Am Coll Cardiol","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.jacc.2011.03.013","article-title":"Second-generation drug-eluting stents. Moving the field forward","volume":"58","author":"Alfonso F,","year":"2011","unstructured":"Alfonso F, Fernandez C: Second-generation drug-eluting stents. Moving the field forward. J Am Coll Cardiol 58:26\u201329, 20112151408510.1016\/j.jacc.2011.03.013"},{"key":"b3-focus16507","series-title":"Am J Cardiol","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1016\/0002-9149(91)90207-2","article-title":"Cutting balloon: a novel approach to percutaneous angioplasty","volume":"68","author":"Barath P,","year":"1991","unstructured":"Barath P, Fishbein MC, Vari S, Forrester JS: Cutting balloon: a novel approach to percutaneous angioplasty. Am J Cardiol 68:1249\u20131252, 199110.1016\/0002-9149(91)90207-2"},{"key":"b4-focus16507","series-title":"J Biomed Mater Res A","doi-asserted-by":"publisher","first-page":"3284","DOI":"10.1002\/jbm.a.35461","article-title":"Oligonucleotide biofunctionalization enhances endothelial progenitor cell adhesion on cobalt\/chromium stents","volume":"103","author":"Barsotti MC,","year":"2015","unstructured":"Barsotti MC, Al Kayal T, Tedeschi L, Dinucci D, Losi P, Sbrana S, : Oligonucleotide biofunctionalization enhances endothelial progenitor cell adhesion on cobalt\/chromium stents. J Biomed Mater Res A 103:3284\u20133292, 201510.1002\/jbm.a.3546125809157"},{"key":"b5-focus16507","series-title":"Catheter Cardiovasc Interv","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1002\/ccd.23143","article-title":"Two-year follow-up of the Genous\u2122 endothelial progenitor cell capturing stent versus the Taxus Libert\u00e9 stent in patients with de novo coronary artery lesions with a high-risk of restenosis: a randomized, single-center, pilot study","volume":"78","author":"Beijk MA,","year":"2011","unstructured":"Beijk MA, Klomp M, van Geloven N, Koch KT, Henriques JP, Baan J, : Two-year follow-up of the Genous\u2122 endothelial progenitor cell capturing stent versus the Taxus Libert\u00e9 stent in patients with de novo coronary artery lesions with a high-risk of restenosis: a randomized, single-center, pilot study. Catheter Cardiovasc Interv 78:189\u2013195, 20112154210910.1002\/ccd.23143"},{"key":"b6-focus16507","series-title":"J Invasive Cardiol","first-page":"227","article-title":"Cutting balloon to treat carotid in-stent stenosis: technical note","volume":"15","author":"Bendok BR,","year":"2003","unstructured":"Bendok BR, Roubin GS, Katzen BT, Boulos AS, Levy EI, Limpijankit T, : Cutting balloon to treat carotid in-stent stenosis: technical note. J Invasive Cardiol 15:227\u2013232, 200312668854"},{"key":"b7-focus16507","series-title":"Cardiovasc Revasc Med","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.carrev.2009.04.007","article-title":"Percutaneous coronary intervention for small vessel coronary artery disease","volume":"11","author":"Biondi-Zoccai G,","year":"2010","unstructured":"Biondi-Zoccai G, Moretti C, Abbate A, Sheiban I: Percutaneous coronary intervention for small vessel coronary artery disease. Cardiovasc Revasc Med 11:189\u2013198, 20102059917410.1016\/j.carrev.2009.04.007"},{"key":"b8-focus16507","series-title":"Lancet","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1016\/S0140-6736(14)61184-3","article-title":"Long-term outcomes after stenting versus endarterectomy for treatment of symptomatic carotid stenosis: the International Carotid Stenting Study (ICSS) randomised trial","volume":"385","author":"Bonati LH,","year":"2015","unstructured":"Bonati LH, Dobson J, Featherstone RL, Ederle J, van der Worp HB, de Borst GJ, : Long-term outcomes after stenting versus endarterectomy for treatment of symptomatic carotid stenosis: the International Carotid Stenting Study (ICSS) randomised trial. Lancet 385:529\u2013538, 20152545344310.1016\/S0140-6736(14)61184-3"},{"key":"b9-focus16507","series-title":"J Stroke Cerebrovasc Dis","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/j.jstrokecerebrovasdis.2011.05.007","article-title":"Vertebral artery origin stenosis and its treatment","volume":"20","author":"Borhani Haghighi A,","year":"2011","unstructured":"Borhani Haghighi A, Edgell RC, Cruz-Flores S, Zaidat OO: Vertebral artery origin stenosis and its treatment. J Stroke Cerebrovasc Dis 20:369\u2013376, 201110.1016\/j.jstrokecerebrovasdis.2011.05.007"},{"key":"b10-focus16507","series-title":"Adv Healthc Mater","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1002\/adhm.201501019","article-title":"Biodegradable metals for cardiovascular stents: from clinical concerns to recent Zn-alloys","volume":"5","author":"Bowen PK,","year":"2016","unstructured":"Bowen PK, Shearier ER, Zhao S, Guillory RJ II, Zhao F, Goldman J, : Biodegradable metals for cardiovascular stents: from clinical concerns to recent Zn-alloys. Adv Healthc Mater 5:1121\u20131140, 201610.1002\/adhm.20150101927094868"},{"key":"b11-focus16507","series-title":"N Engl J Med","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1056\/NEJMoa0912321","article-title":"Stenting versus endarterectomy for treatment of carotid-artery stenosis","volume":"363","author":"Brott TG,","year":"2010","unstructured":"Brott TG, Hobson RW II, Howard G, Roubin GS, Clark WM, Brooks W, : Stenting versus endarterectomy for treatment of carotid-artery stenosis. N Engl J Med 363:11\u201323, 201010.1056\/NEJMoa091232120505173"},{"key":"b12-focus16507","series-title":"ASAIO J","doi-asserted-by":"publisher","first-page":"M853","DOI":"10.1097\/00002480-199407000-00118","article-title":"Biocompatible surfaces using methacryloylphosphorylcholine laurylmethacrylate copolymer","volume":"40","author":"Campbell EJ,","year":"1994","unstructured":"Campbell EJ, O'Byrne V, Stratford PW, Quirk I, Vick TA, Wiles MC, : Biocompatible surfaces using methacryloylphosphorylcholine laurylmethacrylate copolymer. ASAIO J 40:M853\u2013M857, 199410.1097\/00002480-199407000-00118"},{"key":"b13-focus16507","series-title":"Lancet","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1016\/S0140-6736(15)00979-4","article-title":"Everolimus-eluting bioresorbable vascular scaffolds versus everolimus-eluting metallic stents: a meta-analysis of randomised controlled trials","volume":"387","author":"Cassese S,","year":"2016","unstructured":"Cassese S, Byrne RA, Ndrepepa G, Kufner S, Wiebe J, Repp J, : Everolimus-eluting bioresorbable vascular scaffolds versus everolimus-eluting metallic stents: a meta-analysis of randomised controlled trials. Lancet 387:537\u2013544, 201610.1016\/S0140-6736(15)00979-426597771"},{"key":"b14-focus16507","series-title":"Ann Vasc Surg","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1007\/s100169900013","article-title":"Phosphorylcholine coating of ePTFE grafts reduces neointimal hyperplasia in canine model","volume":"11","author":"Chen C,","year":"1997","unstructured":"Chen C, Lumsden AB, Ofenloch JC, Noe B, Campbell EJ, Stratford PW, : Phosphorylcholine coating of ePTFE grafts reduces neointimal hyperplasia in canine model. Ann Vasc Surg 11:74\u201379, 1997906114310.1007\/s100169900013"},{"key":"b15-focus16507","series-title":"N Engl J Med","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1056\/NEJMoa1105335","article-title":"Stenting versus aggressive medical therapy for intracranial arterial stenosis","volume":"365","author":"Chimowitz MI,","year":"2011","unstructured":"Chimowitz MI, Lynn MJ, Derdeyn CP, Turan TN, Fiorella D, Lane BF, : Stenting versus aggressive medical therapy for intracranial arterial stenosis. N Engl J Med 365:993\u20131003, 20112189940910.1056\/NEJMoa1105335"},{"key":"b16-focus16507","series-title":"N Engl J Med","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1056\/NEJMoa043033","article-title":"Comparison of warfarin and aspirin for symptomatic intracranial arterial stenosis","volume":"352","author":"Chimowitz MI,","year":"2005","unstructured":"Chimowitz MI, Lynn MJ, Howlett-Smith H, Stern BJ, Hertzberg VS, Frankel MR, : Comparison of warfarin and aspirin for symptomatic intracranial arterial stenosis. N Engl J Med 352:1305\u20131316, 200510.1056\/NEJMoa04303315800226"},{"key":"b17-focus16507","series-title":"Lancet Neurol","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1016\/S1474-4422(15)00017-4","article-title":"Stenting versus medical treatment in patients with symptomatic vertebral artery stenosis: a randomised open-label phase 2 trial","volume":"14","author":"Compter A,","year":"2015","unstructured":"Compter A, van der Worp HB, Schonewille WJ, Vos JA, Boiten J, Nederkoorn PJ, : Stenting versus medical treatment in patients with symptomatic vertebral artery stenosis: a randomised open-label phase 2 trial. Lancet Neurol 14:606\u2013614, 201510.1016\/S1474-4422(15)00017-425908089"},{"key":"b18-focus16507","series-title":"Circulation","doi-asserted-by":"publisher","first-page":"2257","DOI":"10.1161\/01.CIR.0000163587.36485.A7","article-title":"Molecular basis of restenosis and drug-eluting stents","volume":"111","author":"Costa MA,","year":"2005","unstructured":"Costa MA, Simon DI: Molecular basis of restenosis and drug-eluting stents. Circulation 111:2257\u20132273, 20051586719310.1161\/01.CIR.0000163587.36485.A7"},{"key":"b19-focus16507","series-title":"Stroke","doi-asserted-by":"publisher","first-page":"1526","DOI":"10.1161\/STROKEAHA.106.471862","article-title":"Long-term outcome after angioplasty and stenting for symptomatic vertebral artery stenosis compared with medical treatment in the Carotid And Vertebral Artery Transluminal Angioplasty Study (CAVATAS): a randomized trial","volume":"38","author":"Coward LJ,","year":"2007","unstructured":"Coward LJ, McCabe DJ, Ederle J, Featherstone RL, Clifton A, Brown MM: Long-term outcome after angioplasty and stenting for symptomatic vertebral artery stenosis compared with medical treatment in the Carotid And Vertebral Artery Transluminal Angioplasty Study (CAVATAS): a randomized trial. Stroke 38:1526\u20131530, 200710.1161\/STROKEAHA.106.47186217395869"},{"key":"b20-focus16507","series-title":"Circulation","doi-asserted-by":"publisher","first-page":"2548","DOI":"10.1161\/01.CIR.0000074040.31731.96","article-title":"Inhibitory activity of clinical thiazolidinedione peroxisome proliferator activating receptor-gamma ligands toward internal mammary artery, radial artery, and saphenous vein smooth muscle cell proliferation","volume":"107","author":"de Dios ST,","year":"2003","unstructured":"de Dios ST, Bruemmer D, Dilley RJ, Ivey ME, Jennings GL, Law RE, : Inhibitory activity of clinical thiazolidinedione peroxisome proliferator activating receptor-gamma ligands toward internal mammary artery, radial artery, and saphenous vein smooth muscle cell proliferation. Circulation 107:2548\u20132550, 200310.1161\/01.CIR.0000074040.31731.96"},{"key":"b21-focus16507","series-title":"Curr Interv Cardiol Rep","first-page":"326","article-title":"Anti-restenosis trials","volume":"2","author":"de Feyter PJ,","year":"2000","unstructured":"de Feyter PJ, Vos J, Rensing BJ: Anti-restenosis trials. Curr Interv Cardiol Rep 2:326\u2013331, 2000"},{"key":"b22-focus16507","series-title":"Arch Intern Med","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1001\/archinternmed.2012.758","article-title":"Drug-eluting vs bare-metal stents in primary angioplasty: a pooled patient-level meta-analysis of randomized trials","volume":"172","author":"De Luca G,","year":"2012","unstructured":"De Luca G, Dirksen MT, Spaulding C, Kelbaek H, Schalij M, Thuesen L, : Drug-eluting vs bare-metal stents in primary angioplasty: a pooled patient-level meta-analysis of randomized trials. Arch Intern Med 172:611\u2013622, 201210.1001\/archinternmed.2012.758"},{"key":"b23-focus16507","series-title":"Am Heart J","doi-asserted-by":"publisher","first-page":"e43","DOI":"10.1016\/j.ahj.2009.03.016","article-title":"Benefits of drug-eluting stents as compared to bare metal stent in ST-segment elevation myocardial infarction: four year results of the PaclitAxel or Sirolimus-Eluting stent vs bare metal stent in primary angiOplasty (PASEO) randomized trial.","volume":"158","author":"Di Lorenzo E,","year":"2009","unstructured":"Di Lorenzo E, Sauro R, Varricchio A, Capasso M, Lanzillo T, Manganelli F, : Benefits of drug-eluting stents as compared to bare metal stent in ST-segment elevation myocardial infarction: four year results of the PaclitAxel or Sirolimus-Eluting stent vs bare metal stent in primary angiOplasty (PASEO) randomized trial.. Am Heart J 158:e43\u2013e50, 200910.1016\/j.ahj.2009.03.016"},{"key":"b24-focus16507","series-title":"Neurosurgery","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1227\/NEU.0b013e318271bcb8","article-title":"Revisiting angioplasty without stenting for symptomatic intracranial atherosclerotic stenosis after the stenting and aggressive medical management for preventing recurrent stroke in intracranial stenosis (SAMMPRIS) study","volume":"71","author":"Dumont TM,","year":"2012","unstructured":"Dumont TM, Kan P, Snyder KV, Hopkins LN, Siddiqui AH, Levy EI: Revisiting angioplasty without stenting for symptomatic intracranial atherosclerotic stenosis after the stenting and aggressive medical management for preventing recurrent stroke in intracranial stenosis (SAMMPRIS) study. Neurosurgery 71:1103\u20131110, 201210.1227\/NEU.0b013e318271bcb822986593"},{"key":"b25-focus16507","series-title":"J Neurosurg","doi-asserted-by":"publisher","first-page":"964","DOI":"10.3171\/2015.8.JNS15791","article-title":"Submaximal angioplasty for symptomatic intracranial atherosclerosis: a prospective Phase I study","volume":"125","author":"Dumont TM,","year":"2016","unstructured":"Dumont TM, Sonig A, Mokin M, Eller JL, Sorkin GC, Snyder KV, : Submaximal angioplasty for symptomatic intracranial atherosclerosis: a prospective Phase I study. J Neurosurg 125:964\u2013971, 201610.3171\/2015.8.JNS1579126745485"},{"key":"b26-focus16507","series-title":"Lancet Neurol","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1016\/S1474-4422(09)70228-5","article-title":"Endovascular treatment with angioplasty or stenting versus endarterectomy in patients with carotid artery stenosis in the Carotid and Vertebral Artery Transluminal Angioplasty Study (CAVATAS): long-term follow-up of a randomised trial","volume":"8","author":"Ederle J,","year":"2009","unstructured":"Ederle J, Bonati LH, Dobson J, Featherstone RL, Gaines PA, Beard JD, : Endovascular treatment with angioplasty or stenting versus endarterectomy in patients with carotid artery stenosis in the Carotid and Vertebral Artery Transluminal Angioplasty Study (CAVATAS): long-term follow-up of a randomised trial. Lancet Neurol 8:898\u2013907, 200910.1016\/S1474-4422(09)70228-519717345"},{"key":"b27-focus16507","series-title":"Circulation","doi-asserted-by":"publisher","first-page":"1634","DOI":"10.1161\/CIRCULATIONAHA.108.813667","article-title":"Safety of short-term discontinuation of antiplatelet therapy in patients with drug-eluting stents","volume":"119","author":"Eisenberg MJ,","year":"2009","unstructured":"Eisenberg MJ, Richard PR, Libersan D, Filion KB: Safety of short-term discontinuation of antiplatelet therapy in patients with drug-eluting stents. Circulation 119:1634\u20131642, 20091928963810.1161\/CIRCULATIONAHA.108.813667"},{"key":"b28-focus16507","series-title":"N Engl J Med","doi-asserted-by":"publisher","first-page":"1905","DOI":"10.1056\/NEJMoa1509038","article-title":"Everolimus-eluting bioresorbable scaffolds for coronary artery disease","volume":"373","author":"Ellis SG,","year":"2015","unstructured":"Ellis SG, Kereiakes DJ, Metzger DC, Caputo RP, Rizik DG, Teirstein PS, : Everolimus-eluting bioresorbable scaffolds for coronary artery disease. N Engl J Med 373:1905\u20131915, 20152645755810.1056\/NEJMoa1509038"},{"key":"b29-focus16507","series-title":"Circulation","doi-asserted-by":"publisher","first-page":"2435","DOI":"10.1161\/CIRCULATIONAHA.107.693739","article-title":"Pathological correlates of late drug-eluting stent thrombosis: strut coverage as a marker of endothelialization","volume":"115","author":"Finn AV,","year":"2007","unstructured":"Finn AV, Joner M, Nakazawa G, Kolodgie F, Newell J, John MC, : Pathological correlates of late drug-eluting stent thrombosis: strut coverage as a marker of endothelialization. Circulation 115:2435\u20132441, 20071743814710.1161\/CIRCULATIONAHA.107.693739"},{"key":"b30-focus16507","series-title":"J Endovasc Ther","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1583\/14-4715MR.1","article-title":"Long-term results of drug-eluting balloon angioplasty for treatment of refractory recurrent carotid in-stent restenosis","volume":"21","author":"Gandini R,","year":"2014","unstructured":"Gandini R, Del Giudice C, Da Ros V, Sallustio F, Altobelli S, D'Onofrio A, : Long-term results of drug-eluting balloon angioplasty for treatment of refractory recurrent carotid in-stent restenosis. J Endovasc Ther 21:671\u2013677, 20142529079510.1583\/14-4715MR.1"},{"key":"b31-focus16507","series-title":"Atherosclerosis","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1016\/j.atherosclerosis.2008.05.029","article-title":"Effect of thiazolidinediones on in-stent restenosis in patients after coronary stenting: a meta-analysis of randomized controlled trials","volume":"202","author":"Geng DF,","year":"2009","unstructured":"Geng DF, Jin DM, Wu W, Wang Z, Wang JF: Effect of thiazolidinediones on in-stent restenosis in patients after coronary stenting: a meta-analysis of randomized controlled trials. Atherosclerosis 202:521\u2013528, 20091860210510.1016\/j.atherosclerosis.2008.05.029"},{"key":"b32-focus16507","series-title":"J Neurointerv Surg","article-title":"Thrombogenicity of flow diverters in an ex vivo shunt model: effect of phosphorylcholine surface modification.","author":"Hagen MW,","year":"2016","unstructured":"Hagen MW, Girdhar G, Wainwright J, Hinds MT: Thrombogenicity of flow diverters in an ex vivo shunt model: effect of phosphorylcholine surface modification.. J Neurointerv Surg [epub ahead of print]2016"},{"key":"b33-focus16507","series-title":"Medscape.","article-title":"VIST: Vertebral artery stenting may reduce recurrent stroke.","author":"Hughes S:","year":"2016","unstructured":"Hughes S: VIST: Vertebral artery stenting may reduce recurrent stroke.. Medscape. May302016. (http:\/\/www.medscape.com\/viewarticle\/863997) [Accessed February 14, 2017]"},{"key":"b34-focus16507","series-title":"Biomaterials","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/j.biomaterials.2015.02.047","article-title":"Stem cell impregnated nanofiber stent sleeve for on-stent production and intravascular delivery of paracrine factors","volume":"52","author":"Hwang CW,","year":"2015","unstructured":"Hwang CW, Johnston PV, Gerstenblith G, Weiss RG, Tomaselli GF, Bogdan VE, : Stem cell impregnated nanofiber stent sleeve for on-stent production and intravascular delivery of paracrine factors. Biomaterials 52:318\u2013326, 20152581843810.1016\/j.biomaterials.2015.02.047"},{"key":"b35-focus16507","series-title":"J Biomed Mater Res B Appl Biomater","doi-asserted-by":"publisher","first-page":"1658","DOI":"10.1002\/jbm.b.33510","article-title":"Point-of-care seeding of nitinol stents with blood-derived endothelial cells","volume":"104","author":"Jantzen AE,","year":"2016","unstructured":"Jantzen AE, Noviani M, Mills JS, Baker KM, Lin FH, Truskey GA, : Point-of-care seeding of nitinol stents with blood-derived endothelial cells. J Biomed Mater Res B Appl Biomater 104:1658\u20131665, 201610.1002\/jbm.b.3351026340233"},{"key":"b36-focus16507","series-title":"Neurosurgery","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1227\/NEU.0000000000001146","article-title":"Long-term follow-up of in-stent stenosis after Pipeline flow diversion treatment of intracranial aneurysms","volume":"78","author":"John S,","year":"2016","unstructured":"John S, Bain MD, Hui FK, Hussain MS, Masaryk TJ, Rasmussen PA, : Long-term follow-up of in-stent stenosis after Pipeline flow diversion treatment of intracranial aneurysms. Neurosurgery 78:862\u2013867, 20162660028110.1227\/NEU.0000000000001146"},{"key":"b37-focus16507","series-title":"Am J Cardiol","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.1016\/j.amjcard.2008.07.023","article-title":"Comparison of effectiveness of atorvastatin 10 mg versus 80 mg in reducing major cardiovascular events and repeat revascularization in patients with previous percutaneous coronary intervention (post hoc analysis of the Treating to New Targets [TNT] Study)","volume":"102","author":"Johnson C,","year":"2008","unstructured":"Johnson C, Waters DD, DeMicco DA, Breazna A, Bittner V, Greten H, : Comparison of effectiveness of atorvastatin 10 mg versus 80 mg in reducing major cardiovascular events and repeat revascularization in patients with previous percutaneous coronary intervention (post hoc analysis of the Treating to New Targets [TNT] Study). Am J Cardiol 102:1312\u20131317, 200810.1016\/j.amjcard.2008.07.02318993147"},{"key":"b38-focus16507","series-title":"J Thorac Dis","first-page":"E599","article-title":"Mechanism of in-stent restenosis after second-generation drug-eluting stents (DES): is it different from bare-metal stents and first-generation DES?","volume":"7","author":"Kuramitsu S,","year":"2015","unstructured":"Kuramitsu S, Shirai S, Ando K: Mechanism of in-stent restenosis after second-generation drug-eluting stents (DES): is it different from bare-metal stents and first-generation DES?. J Thorac Dis 7:E599\u2013E602, 2015"},{"key":"b39-focus16507","series-title":"J Am Coll Cardiol","doi-asserted-by":"publisher","first-page":"2473","DOI":"10.1016\/j.jacc.2012.09.020","article-title":"A randomized multicenter study comparing a paclitaxel drug-eluting balloon with a paclitaxel-eluting stent in small coronary vessels: the BELLO (Balloon Elution and Late Loss Optimization) study","volume":"60","author":"Latib A,","year":"2012","unstructured":"Latib A, Colombo A, Castriota F, Micari A, Cremonesi A, De Felice F, : A randomized multicenter study comparing a paclitaxel drug-eluting balloon with a paclitaxel-eluting stent in small coronary vessels: the BELLO (Balloon Elution and Late Loss Optimization) study. J Am Coll Cardiol 60:2473\u20132480, 201210.1016\/j.jacc.2012.09.02023158530"},{"key":"b40-focus16507","series-title":"AJNR Am J Neuroradiol","doi-asserted-by":"publisher","first-page":"487","DOI":"10.3174\/ajnr.A4550","article-title":"Posterior inferior cerebellar artery patency after flow-diverting stent treatment","volume":"37","author":"Levitt MR,","year":"2016","unstructured":"Levitt MR, Park MS, Albuquerque FC, Moon K, Kalani MY, McDougall CG: Posterior inferior cerebellar artery patency after flow-diverting stent treatment. AJNR Am J Neuroradiol 37:487\u2013489, 201610.3174\/ajnr.A455026427829"},{"key":"b41-focus16507","series-title":"Cardiovasc Diabetol","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/1475-2840-8-41","article-title":"The role of glucose lowering agents on restenosis after percutaneous coronary intervention in patients with diabetes mellitus.","volume":"8","author":"Lexis CP,","year":"2009","unstructured":"Lexis CP, Rahel BM, Meeder JG, Zijlstra F, van der Horst IC: The role of glucose lowering agents on restenosis after percutaneous coronary intervention in patients with diabetes mellitus.. Cardiovasc Diabetol 8:41, 20091963517010.1186\/1475-2840-8-41"},{"key":"b42-focus16507","series-title":"J Endovasc Ther","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1583\/JEVT-12-3942R.1","article-title":"Drug-eluting balloon angioplasty for carotid in-stent restenosis","volume":"19","author":"Liistro F,","year":"2012","unstructured":"Liistro F, Porto I, Grotti S, Ventoruzzo G, Vergallo R, Bellandi G, : Drug-eluting balloon angioplasty for carotid in-stent restenosis. J Endovasc Ther 19:729\u2013733, 20122321086910.1583\/JEVT-12-3942R.1"},{"key":"b43-focus16507","series-title":"Circulation","doi-asserted-by":"publisher","first-page":"2233","DOI":"10.1161\/01.CIR.0000163561.90680.1C","article-title":"Dual antiplatelet therapy with clopidogrel and aspirin in symptomatic carotid stenosis evaluated using Doppler embolic signal detection: the Clopidogrel and Aspirin for Reduction of Emboli in Symptomatic Carotid Stenosis (CARESS) trial","volume":"111","author":"Markus HS,","year":"2005","unstructured":"Markus HS, Droste DW, Kaps M, Larrue V, Lees KR, Siebler M, : Dual antiplatelet therapy with clopidogrel and aspirin in symptomatic carotid stenosis evaluated using Doppler embolic signal detection: the Clopidogrel and Aspirin for Reduction of Emboli in Symptomatic Carotid Stenosis (CARESS) trial. Circulation 111:2233\u20132240, 20051585160110.1161\/01.CIR.0000163561.90680.1C"},{"key":"b44-focus16507","series-title":"J Neurointerv Surg","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1136\/neurintsurg-2015-012040","article-title":"Pipeline embolization device for the treatment of vertebral artery aneurysms: the fate of covered branch vessels","volume":"8","author":"Mazur MD,","year":"2016","unstructured":"Mazur MD, Kilburg C, Wang V, Taussky P: Pipeline embolization device for the treatment of vertebral artery aneurysms: the fate of covered branch vessels. J Neurointerv Surg 8:1041\u20131047, 20162649104110.1136\/neurintsurg-2015-012040"},{"key":"b45-focus16507","series-title":"J Endovasc Ther","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1583\/JEVT-12-4042R.1","article-title":"Drug-eluting balloon for treatment of in-stent restenosis after carotid artery stenting: preliminary report","volume":"19","author":"Montorsi P,","year":"2012","unstructured":"Montorsi P, Galli S, Ravagnani PM, Trabattoni D, Fabbiocchi F, Lualdi A, : Drug-eluting balloon for treatment of in-stent restenosis after carotid artery stenting: preliminary report. J Endovasc Ther 19:734\u2013742, 20122321087010.1583\/JEVT-12-4042R.1"},{"key":"b46-focus16507","series-title":"Stroke","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1161\/01.STR.15.2.260","article-title":"Vertebral artery stenosis: long-term follow-up","volume":"15","author":"Moufarrij NA,","year":"1984","unstructured":"Moufarrij NA, Little JR, Furlan AJ, Williams G, Marzewski DJ: Vertebral artery stenosis: long-term follow-up. Stroke 15:260\u2013263, 1984670193410.1161\/01.STR.15.2.260"},{"key":"b47-focus16507","series-title":"Circulation","first-page":"e38","article-title":"Heart Disease and Stroke Statistics\u20142016 Update: a report from the American Heart Association","volume":"133","author":"Mozaffarian D,","year":"2016","unstructured":"Mozaffarian D, Benjamin EJ, Go AS, Arnett DK, Blaha MJ, Cushman M, : Heart Disease and Stroke Statistics\u20142016 Update: a report from the American Heart Association. Circulation 133:e38\u2013e360, 2016. (Erratum in Circulation 133: e599, 2016)"},{"key":"b48-focus16507","series-title":"J Invasive Cardiol","first-page":"439","article-title":"Efficacy of cutting balloon angioplasty for in-stent restenosis: an intravascular ultrasound evaluation","volume":"13","author":"Muramatsu T,","year":"2001","unstructured":"Muramatsu T, Tsukahara R, Ho M, Ito Y, Hirano K, Ishimori H, : Efficacy of cutting balloon angioplasty for in-stent restenosis: an intravascular ultrasound evaluation. J Invasive Cardiol 13:439\u2013444, 200111385165"},{"key":"b49-focus16507","series-title":"Int J Cardiol","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.ijcard.2015.01.080","article-title":"A 2-year follow-up of a randomized multicenter study comparing a paclitaxel drug-eluting balloon with a paclitaxel-eluting stent in small coronary vessels the BELLO study","volume":"184","author":"Naganuma T,","year":"2015","unstructured":"Naganuma T, Latib A, Sgueglia GA, Menozzi A, Castriota F, Micari A, : A 2-year follow-up of a randomized multicenter study comparing a paclitaxel drug-eluting balloon with a paclitaxel-eluting stent in small coronary vessels the BELLO study. Int J Cardiol 184:17\u201321, 201510.1016\/j.ijcard.2015.01.08025705005"},{"key":"b50-focus16507","series-title":"AJNR Am J Neuroradiol","doi-asserted-by":"publisher","first-page":"34","DOI":"10.3174\/ajnr.A2421","article-title":"The pipeline embolization device for the intracranial treatment of aneurysms trial","volume":"32","author":"Nelson PK,","year":"2011","unstructured":"Nelson PK, Lylyk P, Szikora I, Wetzel SG, Wanke I, Fiorella D: The pipeline embolization device for the intracranial treatment of aneurysms trial. AJNR Am J Neuroradiol 32:34\u201340, 20112114825610.3174\/ajnr.A2421"},{"key":"b51-focus16507","series-title":"N Engl J Med","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1056\/NEJM199108153250701","article-title":"Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis","volume":"325","author":"North American Symptomatic Carotid Endarterectomy Trial Collaborators","year":"1991","unstructured":"North American Symptomatic Carotid Endarterectomy Trial Collaborators: Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis. N Engl J Med 325:445\u2013453, 199110.1056\/NEJM1991081532507011852179"},{"key":"b52-focus16507","series-title":"Ann Biomed Eng","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1007\/s10439-015-1380-x","article-title":"Coronary stent materials and coatings: a technology and performance update","volume":"44","author":"O'Brien B,","year":"2016","unstructured":"O'Brien B, Zafar H, Ibrahim A, Zafar J, Sharif F: Coronary stent materials and coatings: a technology and performance update. Ann Biomed Eng 44:523\u2013535, 20162613929710.1007\/s10439-015-1380-x"},{"key":"b53-focus16507","series-title":"Circulation","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1161\/CIRCULATIONAHA.110.971606","article-title":"Bioresorbable scaffold: the advent of a new era in percutaneous coronary and peripheral revascularization?","volume":"123","author":"Onuma Y,","year":"2011","unstructured":"Onuma Y, Serruys PW: Bioresorbable scaffold: the advent of a new era in percutaneous coronary and peripheral revascularization?. Circulation 123:779\u2013797, 20112134359410.1161\/CIRCULATIONAHA.110.971606"},{"key":"b54-focus16507","series-title":"Circulation","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1161\/CIRCULATIONAHA.113.001790","article-title":"Pathology of second-generation everolimus-eluting stents versus first-generation sirolimus- and paclitaxel-eluting stents in humans","volume":"129","author":"Otsuka F,","year":"2014","unstructured":"Otsuka F, Vorpahl M, Nakano M, Foerst J, Newell JB, Sakakura K, : Pathology of second-generation everolimus-eluting stents versus first-generation sirolimus- and paclitaxel-eluting stents in humans. Circulation 129:211\u2013223, 20142416306410.1161\/CIRCULATIONAHA.113.001790"},{"key":"b55-focus16507","series-title":"Neurosurgery","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1227\/01.NEU.0000370010.09419.23","article-title":"Vertebral artery origin stents revisited: improved results with paclitaxel-eluting stents","volume":"67","author":"Park MS,","year":"2010","unstructured":"Park MS, Fiorella D, Stiefel MF, Dashti SR, Gonzalez LF, McDougall CG, : Vertebral artery origin stents revisited: improved results with paclitaxel-eluting stents. Neurosurgery 67:41\u201348, 20102056866610.1227\/01.NEU.0000370010.09419.23"},{"key":"b56-focus16507","series-title":"J Endovasc Ther","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1177\/1526602815573498","article-title":"Drug-coated balloon dilation before carotid artery stenting of post-carotid endarterectomy restenosis","volume":"22","author":"Piccoli G,","year":"2015","unstructured":"Piccoli G, Biondi-Zoccai G, Gavrilovic V, Radici V, Cancelli I, Frigatti P, : Drug-coated balloon dilation before carotid artery stenting of post-carotid endarterectomy restenosis. J Endovasc Ther 22:212\u2013216, 20152580936410.1177\/1526602815573498"},{"key":"b57-focus16507","series-title":"Cardiovasc Ther","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1111\/j.1755-5922.2011.00302.x","article-title":"Do statins have a role in reduction\/prevention of post-PCI restenosis?","volume":"31","author":"Prasad K:","year":"2013","unstructured":"Prasad K: Do statins have a role in reduction\/prevention of post-PCI restenosis?. Cardiovasc Ther 31:12\u201326, 20132196767410.1111\/j.1755-5922.2011.00302.x"},{"key":"b58-focus16507","series-title":"Stroke","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1161\/01.STR.26.1.14","article-title":"Race-ethnicity and determinants of intracranial atherosclerotic cerebral infarction. The Northern Manhattan Stroke Study","volume":"26","author":"Sacco RL,","year":"1995","unstructured":"Sacco RL, Kargman DE, Gu Q, Zamanillo MC: Race-ethnicity and determinants of intracranial atherosclerotic cerebral infarction. The Northern Manhattan Stroke Study. Stroke 26:14\u201320, 1995783938810.1161\/01.STR.26.1.14"},{"key":"b59-focus16507","series-title":"N Engl J Med","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1056\/NEJMra051091","article-title":"Coronary-artery stents","volume":"354","author":"Serruys PW,","year":"2006","unstructured":"Serruys PW, Kutryk MJ, Ong AT: Coronary-artery stents. N Engl J Med 354:483\u2013495, 200610.1056\/NEJMra05109116452560"},{"key":"b60-focus16507","series-title":"N Engl J Med","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1056\/NEJM200104123441502","article-title":"Comparison of coronary-artery bypass surgery and stenting for the treatment of multivessel disease","volume":"344","author":"Serruys PW,","year":"2001","unstructured":"Serruys PW, Unger F, Sousa JE, Jatene A, Bonnier HJ, Sch\u00f6nberger JP, : Comparison of coronary-artery bypass surgery and stenting for the treatment of multivessel disease. N Engl J Med 344:1117\u20131124, 200110.1056\/NEJM20010412344150211297702"},{"key":"b61-focus16507","series-title":"J Am Coll Cardiol","doi-asserted-by":"publisher","first-page":"1757","DOI":"10.1016\/j.jacc.2003.04.001","article-title":"The effects of rosiglitazone, a peroxisome proliferator-activated receptor-gamma agonist, on markers of endothelial cell activation, C-reactive protein, and fibrinogen levels in non-diabetic coronary artery disease patients","volume":"42","author":"Sidhu JS,","year":"2003","unstructured":"Sidhu JS, Cowan D, Kaski JC: The effects of rosiglitazone, a peroxisome proliferator-activated receptor-gamma agonist, on markers of endothelial cell activation, C-reactive protein, and fibrinogen levels in non-diabetic coronary artery disease patients. J Am Coll Cardiol 42:1757\u20131763, 200310.1016\/j.jacc.2003.04.00114642684"},{"key":"b62-focus16507","series-title":"Eur Rev Med Pharmacol Sci","first-page":"311","article-title":"Study of a novel coating strategy for coronary stents: evaluation of stainless metallic steel coated with VEGF and anti-CD34 antibody in vitro","volume":"20","author":"Song CL,","year":"2016","unstructured":"Song CL, Li Q, Zhang JC, Wang JP, Xue X, Wang G, : Study of a novel coating strategy for coronary stents: evaluation of stainless metallic steel coated with VEGF and anti-CD34 antibody in vitro. Eur Rev Med Pharmacol Sci 20:311\u2013316, 201626875902"},{"key":"b63-focus16507","series-title":"N Engl J Med","doi-asserted-by":"publisher","first-page":"1946","DOI":"10.1056\/NEJMoa0810116","article-title":"Paclitaxel-eluting stents versus bare-metal stents in acute myocardial infarction","volume":"360","author":"Stone GW,","year":"2009","unstructured":"Stone GW, Lansky AJ, Pocock SJ, Gersh BJ, Dangas G, Wong SC, : Paclitaxel-eluting stents versus bare-metal stents in acute myocardial infarction. N Engl J Med 360:1946\u20131959, 200910.1056\/NEJMoa081011619420364"},{"key":"b64-focus16507","series-title":"J Invasive Cardiol","first-page":"133","article-title":"Cutting balloon angioplasty to treat carotid in-stent restenosis","volume":"16","author":"Tamberella MR,","year":"2004","unstructured":"Tamberella MR, Yadav JS, Bajzer CT, Bhatt DL, Abou-Chebl A: Cutting balloon angioplasty to treat carotid in-stent restenosis. J Invasive Cardiol 16:133\u2013135, 200415152163"},{"key":"b65-focus16507","series-title":"J Neurointerv Surg","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1136\/neurintsurg-2015-011697","article-title":"Drug eluting stents versus bare metal stents for the treatment of extracranial vertebral artery disease: a meta-analysis","volume":"8","author":"Tank VH,","year":"2016","unstructured":"Tank VH, Ghosh R, Gupta V, Sheth N, Gordon S, He W, : Drug eluting stents versus bare metal stents for the treatment of extracranial vertebral artery disease: a meta-analysis. J Neurointerv Surg 8:770\u2013774, 20162618009410.1136\/neurintsurg-2015-011697"},{"key":"b66-focus16507","series-title":"AJNR Am J Neuroradiol","doi-asserted-by":"publisher","first-page":"1653","DOI":"10.3174\/ajnr.A1715","article-title":"Treatment of stenoses of vertebral artery origin using short drug-eluting coronary stents: improved follow-up results","volume":"30","author":"Vajda Z,","year":"2009","unstructured":"Vajda Z, Miloslavski E, G\u00fcthe T, Fischer S, Albes G, Heuschmid A, : Treatment of stenoses of vertebral artery origin using short drug-eluting coronary stents: improved follow-up results. AJNR Am J Neuroradiol 30:1653\u20131656, 200910.3174\/ajnr.A171519729536"},{"key":"b67-focus16507","series-title":"J Vasc Interv Radiol","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.1016\/j.jvir.2010.06.010","article-title":"Therapeutic options for carotid in-stent restenosis: review of the literature","volume":"21","author":"van Haaften AC,","year":"2010","unstructured":"van Haaften AC, Bots ML, Moll FL, de Borst GJ: Therapeutic options for carotid in-stent restenosis: review of the literature. J Vasc Interv Radiol 21:1471\u20131477, 201010.1016\/j.jvir.2010.06.010"},{"key":"b68-focus16507","series-title":"Diagn Interv Radiol","first-page":"345","article-title":"Flow diverter as a rescue therapy for a complicated basilar angioplasty","volume":"19","author":"Velioglu M,","year":"2013","unstructured":"Velioglu M, Ozturk E, Sonmez G, Kendirli T, Mutlu H, Basekim C: Flow diverter as a rescue therapy for a complicated basilar angioplasty. Diagn Interv Radiol 19:345\u2013348, 201323439254"},{"key":"b69-focus16507","series-title":"N Engl J Med","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1056\/NEJMoa040127","article-title":"Protected carotid-artery stenting versus endarterectomy in high-risk patients","volume":"351","author":"Yadav JS,","year":"2004","unstructured":"Yadav JS, Wholey MH, Kuntz RE, Fayad P, Katzen BT, Mishkel GJ, : Protected carotid-artery stenting versus endarterectomy in high-risk patients. N Engl J Med 351:1493\u20131501, 20041547021210.1056\/NEJMoa040127"},{"key":"b70-focus16507","series-title":"JAMA","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1001\/jama.2015.1693","article-title":"Effect of a balloon-expandable intracranial stent vs medical therapy on risk of stroke in patients with symptomatic intracranial stenosis: the VISSIT randomized clinical trial","volume":"313","author":"Zaidat OO,","year":"2015","unstructured":"Zaidat OO, Fitzsimmons BF, Woodward BK, Wang Z, Killer-Oberpfalzer M, Wakhloo A, : Effect of a balloon-expandable intracranial stent vs medical therapy on risk of stroke in patients with symptomatic intracranial stenosis: the VISSIT randomized clinical trial. JAMA 313:1240\u20131248, 201510.1001\/jama.2015.169325803346"},{"key":"b71-focus16507","series-title":"J Mater Sci Mater Med","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1007\/s10856-016-5693-6","article-title":"Constructing bio-layer of heparin and type IV collagen on titanium surface for improving its endothelialization and blood compatibility.","volume":"27","author":"Zhang K,","year":"2016","unstructured":"Zhang K, Chen JY, Qin W, Li JA, Guan FX, Huang N: Constructing bio-layer of heparin and type IV collagen on titanium surface for improving its endothelialization and blood compatibility.. J Mater Sci Mater Med 27:81, 201610.1007\/s10856-016-5693-626936367"},{"key":"b1-focus16507","series-title":"Am J Cardiol","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.1016\/j.amjcard.2005.11.034","article-title":"Comparison of sirolimus versus paclitaxel eluting stents for treatment of coronary in-stent restenosis","volume":"97","author":"Airoldi F,","year":"2006","unstructured":"Airoldi F, Briguori C, Iakovou I, Stankovic G, Biondi-Zoccai G, Carlino M, : Comparison of sirolimus versus paclitaxel eluting stents for treatment of coronary in-stent restenosis. Am J Cardiol 97:1182\u20131187, 20061661602310.1016\/j.amjcard.2005.11.034"},{"key":"b2-focus16507","series-title":"J Am Coll Cardiol","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.jacc.2011.03.013","article-title":"Second-generation drug-eluting stents. Moving the field forward","volume":"58","author":"Alfonso F,","year":"2011","unstructured":"Alfonso F, Fernandez C: Second-generation drug-eluting stents. Moving the field forward. J Am Coll Cardiol 58:26\u201329, 20112151408510.1016\/j.jacc.2011.03.013"},{"key":"b3-focus16507","series-title":"Am J Cardiol","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1016\/0002-9149(91)90207-2","article-title":"Cutting balloon: a novel approach to percutaneous angioplasty","volume":"68","author":"Barath P,","year":"1991","unstructured":"Barath P, Fishbein MC, Vari S, Forrester JS: Cutting balloon: a novel approach to percutaneous angioplasty. Am J Cardiol 68:1249\u20131252, 199110.1016\/0002-9149(91)90207-2"},{"key":"b4-focus16507","series-title":"J Biomed Mater Res A","doi-asserted-by":"publisher","first-page":"3284","DOI":"10.1002\/jbm.a.35461","article-title":"Oligonucleotide biofunctionalization enhances endothelial progenitor cell adhesion on cobalt\/chromium stents","volume":"103","author":"Barsotti MC,","year":"2015","unstructured":"Barsotti MC, Al Kayal T, Tedeschi L, Dinucci D, Losi P, Sbrana S, : Oligonucleotide biofunctionalization enhances endothelial progenitor cell adhesion on cobalt\/chromium stents. J Biomed Mater Res A 103:3284\u20133292, 201510.1002\/jbm.a.3546125809157"},{"key":"b5-focus16507","series-title":"Catheter Cardiovasc Interv","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1002\/ccd.23143","article-title":"Two-year follow-up of the Genous\u2122 endothelial progenitor cell capturing stent versus the Taxus Libert\u00e9 stent in patients with de novo coronary artery lesions with a high-risk of restenosis: a randomized, single-center, pilot study","volume":"78","author":"Beijk MA,","year":"2011","unstructured":"Beijk MA, Klomp M, van Geloven N, Koch KT, Henriques JP, Baan J, : Two-year follow-up of the Genous\u2122 endothelial progenitor cell capturing stent versus the Taxus Libert\u00e9 stent in patients with de novo coronary artery lesions with a high-risk of restenosis: a randomized, single-center, pilot study. Catheter Cardiovasc Interv 78:189\u2013195, 20112154210910.1002\/ccd.23143"},{"key":"b6-focus16507","series-title":"J Invasive Cardiol","first-page":"227","article-title":"Cutting balloon to treat carotid in-stent stenosis: technical note","volume":"15","author":"Bendok BR,","year":"2003","unstructured":"Bendok BR, Roubin GS, Katzen BT, Boulos AS, Levy EI, Limpijankit T, : Cutting balloon to treat carotid in-stent stenosis: technical note. J Invasive Cardiol 15:227\u2013232, 200312668854"},{"key":"b7-focus16507","series-title":"Cardiovasc Revasc Med","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.carrev.2009.04.007","article-title":"Percutaneous coronary intervention for small vessel coronary artery disease","volume":"11","author":"Biondi-Zoccai G,","year":"2010","unstructured":"Biondi-Zoccai G, Moretti C, Abbate A, Sheiban I: Percutaneous coronary intervention for small vessel coronary artery disease. Cardiovasc Revasc Med 11:189\u2013198, 20102059917410.1016\/j.carrev.2009.04.007"},{"key":"b8-focus16507","series-title":"Lancet","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1016\/S0140-6736(14)61184-3","article-title":"Long-term outcomes after stenting versus endarterectomy for treatment of symptomatic carotid stenosis: the International Carotid Stenting Study (ICSS) randomised trial","volume":"385","author":"Bonati LH,","year":"2015","unstructured":"Bonati LH, Dobson J, Featherstone RL, Ederle J, van der Worp HB, de Borst GJ, : Long-term outcomes after stenting versus endarterectomy for treatment of symptomatic carotid stenosis: the International Carotid Stenting Study (ICSS) randomised trial. Lancet 385:529\u2013538, 20152545344310.1016\/S0140-6736(14)61184-3"},{"key":"b9-focus16507","series-title":"J Stroke Cerebrovasc Dis","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/j.jstrokecerebrovasdis.2011.05.007","article-title":"Vertebral artery origin stenosis and its treatment","volume":"20","author":"Borhani Haghighi A,","year":"2011","unstructured":"Borhani Haghighi A, Edgell RC, Cruz-Flores S, Zaidat OO: Vertebral artery origin stenosis and its treatment. J Stroke Cerebrovasc Dis 20:369\u2013376, 201110.1016\/j.jstrokecerebrovasdis.2011.05.007"},{"key":"b10-focus16507","series-title":"Adv Healthc Mater","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1002\/adhm.201501019","article-title":"Biodegradable metals for cardiovascular stents: from clinical concerns to recent Zn-alloys","volume":"5","author":"Bowen PK,","year":"2016","unstructured":"Bowen PK, Shearier ER, Zhao S, Guillory RJ II, Zhao F, Goldman J, : Biodegradable metals for cardiovascular stents: from clinical concerns to recent Zn-alloys. Adv Healthc Mater 5:1121\u20131140, 201610.1002\/adhm.20150101927094868"},{"key":"b11-focus16507","series-title":"N Engl J Med","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1056\/NEJMoa0912321","article-title":"Stenting versus endarterectomy for treatment of carotid-artery stenosis","volume":"363","author":"Brott TG,","year":"2010","unstructured":"Brott TG, Hobson RW II, Howard G, Roubin GS, Clark WM, Brooks W, : Stenting versus endarterectomy for treatment of carotid-artery stenosis. N Engl J Med 363:11\u201323, 201010.1056\/NEJMoa091232120505173"},{"key":"b12-focus16507","series-title":"ASAIO J","doi-asserted-by":"publisher","first-page":"M853","DOI":"10.1097\/00002480-199407000-00118","article-title":"Biocompatible surfaces using methacryloylphosphorylcholine laurylmethacrylate copolymer","volume":"40","author":"Campbell EJ,","year":"1994","unstructured":"Campbell EJ, O'Byrne V, Stratford PW, Quirk I, Vick TA, Wiles MC, : Biocompatible surfaces using methacryloylphosphorylcholine laurylmethacrylate copolymer. ASAIO J 40:M853\u2013M857, 199410.1097\/00002480-199407000-00118"},{"key":"b13-focus16507","series-title":"Lancet","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1016\/S0140-6736(15)00979-4","article-title":"Everolimus-eluting bioresorbable vascular scaffolds versus everolimus-eluting metallic stents: a meta-analysis of randomised controlled trials","volume":"387","author":"Cassese S,","year":"2016","unstructured":"Cassese S, Byrne RA, Ndrepepa G, Kufner S, Wiebe J, Repp J, : Everolimus-eluting bioresorbable vascular scaffolds versus everolimus-eluting metallic stents: a meta-analysis of randomised controlled trials. Lancet 387:537\u2013544, 201610.1016\/S0140-6736(15)00979-426597771"},{"key":"b14-focus16507","series-title":"Ann Vasc Surg","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1007\/s100169900013","article-title":"Phosphorylcholine coating of ePTFE grafts reduces neointimal hyperplasia in canine model","volume":"11","author":"Chen C,","year":"1997","unstructured":"Chen C, Lumsden AB, Ofenloch JC, Noe B, Campbell EJ, Stratford PW, : Phosphorylcholine coating of ePTFE grafts reduces neointimal hyperplasia in canine model. Ann Vasc Surg 11:74\u201379, 1997906114310.1007\/s100169900013"},{"key":"b15-focus16507","series-title":"N Engl J Med","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1056\/NEJMoa1105335","article-title":"Stenting versus aggressive medical therapy for intracranial arterial stenosis","volume":"365","author":"Chimowitz MI,","year":"2011","unstructured":"Chimowitz MI, Lynn MJ, Derdeyn CP, Turan TN, Fiorella D, Lane BF, : Stenting versus aggressive medical therapy for intracranial arterial stenosis. N Engl J Med 365:993\u20131003, 20112189940910.1056\/NEJMoa1105335"},{"key":"b16-focus16507","series-title":"N Engl J Med","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1056\/NEJMoa043033","article-title":"Comparison of warfarin and aspirin for symptomatic intracranial arterial stenosis","volume":"352","author":"Chimowitz MI,","year":"2005","unstructured":"Chimowitz MI, Lynn MJ, Howlett-Smith H, Stern BJ, Hertzberg VS, Frankel MR, : Comparison of warfarin and aspirin for symptomatic intracranial arterial stenosis. N Engl J Med 352:1305\u20131316, 200510.1056\/NEJMoa04303315800226"},{"key":"b17-focus16507","series-title":"Lancet Neurol","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1016\/S1474-4422(15)00017-4","article-title":"Stenting versus medical treatment in patients with symptomatic vertebral artery stenosis: a randomised open-label phase 2 trial","volume":"14","author":"Compter A,","year":"2015","unstructured":"Compter A, van der Worp HB, Schonewille WJ, Vos JA, Boiten J, Nederkoorn PJ, : Stenting versus medical treatment in patients with symptomatic vertebral artery stenosis: a randomised open-label phase 2 trial. Lancet Neurol 14:606\u2013614, 201510.1016\/S1474-4422(15)00017-425908089"},{"key":"b18-focus16507","series-title":"Circulation","doi-asserted-by":"publisher","first-page":"2257","DOI":"10.1161\/01.CIR.0000163587.36485.A7","article-title":"Molecular basis of restenosis and drug-eluting stents","volume":"111","author":"Costa MA,","year":"2005","unstructured":"Costa MA, Simon DI: Molecular basis of restenosis and drug-eluting stents. Circulation 111:2257\u20132273, 20051586719310.1161\/01.CIR.0000163587.36485.A7"},{"key":"b19-focus16507","series-title":"Stroke","doi-asserted-by":"publisher","first-page":"1526","DOI":"10.1161\/STROKEAHA.106.471862","article-title":"Long-term outcome after angioplasty and stenting for symptomatic vertebral artery stenosis compared with medical treatment in the Carotid And Vertebral Artery Transluminal Angioplasty Study (CAVATAS): a randomized trial","volume":"38","author":"Coward LJ,","year":"2007","unstructured":"Coward LJ, McCabe DJ, Ederle J, Featherstone RL, Clifton A, Brown MM: Long-term outcome after angioplasty and stenting for symptomatic vertebral artery stenosis compared with medical treatment in the Carotid And Vertebral Artery Transluminal Angioplasty Study (CAVATAS): a randomized trial. Stroke 38:1526\u20131530, 200710.1161\/STROKEAHA.106.47186217395869"},{"key":"b20-focus16507","series-title":"Circulation","doi-asserted-by":"publisher","first-page":"2548","DOI":"10.1161\/01.CIR.0000074040.31731.96","article-title":"Inhibitory activity of clinical thiazolidinedione peroxisome proliferator activating receptor-gamma ligands toward internal mammary artery, radial artery, and saphenous vein smooth muscle cell proliferation","volume":"107","author":"de Dios ST,","year":"2003","unstructured":"de Dios ST, Bruemmer D, Dilley RJ, Ivey ME, Jennings GL, Law RE, : Inhibitory activity of clinical thiazolidinedione peroxisome proliferator activating receptor-gamma ligands toward internal mammary artery, radial artery, and saphenous vein smooth muscle cell proliferation. Circulation 107:2548\u20132550, 200310.1161\/01.CIR.0000074040.31731.96"},{"key":"b21-focus16507","series-title":"Curr Interv Cardiol Rep","first-page":"326","article-title":"Anti-restenosis trials","volume":"2","author":"de Feyter PJ,","year":"2000","unstructured":"de Feyter PJ, Vos J, Rensing BJ: Anti-restenosis trials. Curr Interv Cardiol Rep 2:326\u2013331, 2000"},{"key":"b22-focus16507","series-title":"Arch Intern Med","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1001\/archinternmed.2012.758","article-title":"Drug-eluting vs bare-metal stents in primary angioplasty: a pooled patient-level meta-analysis of randomized trials","volume":"172","author":"De Luca G,","year":"2012","unstructured":"De Luca G, Dirksen MT, Spaulding C, Kelbaek H, Schalij M, Thuesen L, : Drug-eluting vs bare-metal stents in primary angioplasty: a pooled patient-level meta-analysis of randomized trials. Arch Intern Med 172:611\u2013622, 201210.1001\/archinternmed.2012.758"},{"key":"b23-focus16507","series-title":"Am Heart J","doi-asserted-by":"publisher","first-page":"e43","DOI":"10.1016\/j.ahj.2009.03.016","article-title":"Benefits of drug-eluting stents as compared to bare metal stent in ST-segment elevation myocardial infarction: four year results of the PaclitAxel or Sirolimus-Eluting stent vs bare metal stent in primary angiOplasty (PASEO) randomized trial.","volume":"158","author":"Di Lorenzo E,","year":"2009","unstructured":"Di Lorenzo E, Sauro R, Varricchio A, Capasso M, Lanzillo T, Manganelli F, : Benefits of drug-eluting stents as compared to bare metal stent in ST-segment elevation myocardial infarction: four year results of the PaclitAxel or Sirolimus-Eluting stent vs bare metal stent in primary angiOplasty (PASEO) randomized trial.. Am Heart J 158:e43\u2013e50, 200910.1016\/j.ahj.2009.03.016"},{"key":"b24-focus16507","series-title":"Neurosurgery","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1227\/NEU.0b013e318271bcb8","article-title":"Revisiting angioplasty without stenting for symptomatic intracranial atherosclerotic stenosis after the stenting and aggressive medical management for preventing recurrent stroke in intracranial stenosis (SAMMPRIS) study","volume":"71","author":"Dumont TM,","year":"2012","unstructured":"Dumont TM, Kan P, Snyder KV, Hopkins LN, Siddiqui AH, Levy EI: Revisiting angioplasty without stenting for symptomatic intracranial atherosclerotic stenosis after the stenting and aggressive medical management for preventing recurrent stroke in intracranial stenosis (SAMMPRIS) study. Neurosurgery 71:1103\u20131110, 201210.1227\/NEU.0b013e318271bcb822986593"},{"key":"b25-focus16507","series-title":"J Neurosurg","doi-asserted-by":"publisher","first-page":"964","DOI":"10.3171\/2015.8.JNS15791","article-title":"Submaximal angioplasty for symptomatic intracranial atherosclerosis: a prospective Phase I study","volume":"125","author":"Dumont TM,","year":"2016","unstructured":"Dumont TM, Sonig A, Mokin M, Eller JL, Sorkin GC, Snyder KV, : Submaximal angioplasty for symptomatic intracranial atherosclerosis: a prospective Phase I study. J Neurosurg 125:964\u2013971, 201610.3171\/2015.8.JNS1579126745485"},{"key":"b26-focus16507","series-title":"Lancet Neurol","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1016\/S1474-4422(09)70228-5","article-title":"Endovascular treatment with angioplasty or stenting versus endarterectomy in patients with carotid artery stenosis in the Carotid and Vertebral Artery Transluminal Angioplasty Study (CAVATAS): long-term follow-up of a randomised trial","volume":"8","author":"Ederle J,","year":"2009","unstructured":"Ederle J, Bonati LH, Dobson J, Featherstone RL, Gaines PA, Beard JD, : Endovascular treatment with angioplasty or stenting versus endarterectomy in patients with carotid artery stenosis in the Carotid and Vertebral Artery Transluminal Angioplasty Study (CAVATAS): long-term follow-up of a randomised trial. Lancet Neurol 8:898\u2013907, 200910.1016\/S1474-4422(09)70228-519717345"},{"key":"b27-focus16507","series-title":"Circulation","doi-asserted-by":"publisher","first-page":"1634","DOI":"10.1161\/CIRCULATIONAHA.108.813667","article-title":"Safety of short-term discontinuation of antiplatelet therapy in patients with drug-eluting stents","volume":"119","author":"Eisenberg MJ,","year":"2009","unstructured":"Eisenberg MJ, Richard PR, Libersan D, Filion KB: Safety of short-term discontinuation of antiplatelet therapy in patients with drug-eluting stents. Circulation 119:1634\u20131642, 20091928963810.1161\/CIRCULATIONAHA.108.813667"},{"key":"b28-focus16507","series-title":"N Engl J Med","doi-asserted-by":"publisher","first-page":"1905","DOI":"10.1056\/NEJMoa1509038","article-title":"Everolimus-eluting bioresorbable scaffolds for coronary artery disease","volume":"373","author":"Ellis SG,","year":"2015","unstructured":"Ellis SG, Kereiakes DJ, Metzger DC, Caputo RP, Rizik DG, Teirstein PS, : Everolimus-eluting bioresorbable scaffolds for coronary artery disease. N Engl J Med 373:1905\u20131915, 20152645755810.1056\/NEJMoa1509038"},{"key":"b29-focus16507","series-title":"Circulation","doi-asserted-by":"publisher","first-page":"2435","DOI":"10.1161\/CIRCULATIONAHA.107.693739","article-title":"Pathological correlates of late drug-eluting stent thrombosis: strut coverage as a marker of endothelialization","volume":"115","author":"Finn AV,","year":"2007","unstructured":"Finn AV, Joner M, Nakazawa G, Kolodgie F, Newell J, John MC, : Pathological correlates of late drug-eluting stent thrombosis: strut coverage as a marker of endothelialization. Circulation 115:2435\u20132441, 20071743814710.1161\/CIRCULATIONAHA.107.693739"},{"key":"b30-focus16507","series-title":"J Endovasc Ther","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1583\/14-4715MR.1","article-title":"Long-term results of drug-eluting balloon angioplasty for treatment of refractory recurrent carotid in-stent restenosis","volume":"21","author":"Gandini R,","year":"2014","unstructured":"Gandini R, Del Giudice C, Da Ros V, Sallustio F, Altobelli S, D'Onofrio A, : Long-term results of drug-eluting balloon angioplasty for treatment of refractory recurrent carotid in-stent restenosis. J Endovasc Ther 21:671\u2013677, 20142529079510.1583\/14-4715MR.1"},{"key":"b31-focus16507","series-title":"Atherosclerosis","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1016\/j.atherosclerosis.2008.05.029","article-title":"Effect of thiazolidinediones on in-stent restenosis in patients after coronary stenting: a meta-analysis of randomized controlled trials","volume":"202","author":"Geng DF,","year":"2009","unstructured":"Geng DF, Jin DM, Wu W, Wang Z, Wang JF: Effect of thiazolidinediones on in-stent restenosis in patients after coronary stenting: a meta-analysis of randomized controlled trials. Atherosclerosis 202:521\u2013528, 20091860210510.1016\/j.atherosclerosis.2008.05.029"},{"key":"b32-focus16507","series-title":"J Neurointerv Surg","article-title":"Thrombogenicity of flow diverters in an ex vivo shunt model: effect of phosphorylcholine surface modification.","author":"Hagen MW,","year":"2016","unstructured":"Hagen MW, Girdhar G, Wainwright J, Hinds MT: Thrombogenicity of flow diverters in an ex vivo shunt model: effect of phosphorylcholine surface modification.. J Neurointerv Surg [epub ahead of print]2016"},{"key":"b33-focus16507","series-title":"Medscape.","article-title":"VIST: Vertebral artery stenting may reduce recurrent stroke.","author":"Hughes S:","year":"2016","unstructured":"Hughes S: VIST: Vertebral artery stenting may reduce recurrent stroke.. Medscape. May302016. (http:\/\/www.medscape.com\/viewarticle\/863997) [Accessed February 14, 2017]"},{"key":"b34-focus16507","series-title":"Biomaterials","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/j.biomaterials.2015.02.047","article-title":"Stem cell impregnated nanofiber stent sleeve for on-stent production and intravascular delivery of paracrine factors","volume":"52","author":"Hwang CW,","year":"2015","unstructured":"Hwang CW, Johnston PV, Gerstenblith G, Weiss RG, Tomaselli GF, Bogdan VE, : Stem cell impregnated nanofiber stent sleeve for on-stent production and intravascular delivery of paracrine factors. Biomaterials 52:318\u2013326, 20152581843810.1016\/j.biomaterials.2015.02.047"},{"key":"b35-focus16507","series-title":"J Biomed Mater Res B Appl Biomater","doi-asserted-by":"publisher","first-page":"1658","DOI":"10.1002\/jbm.b.33510","article-title":"Point-of-care seeding of nitinol stents with blood-derived endothelial cells","volume":"104","author":"Jantzen AE,","year":"2016","unstructured":"Jantzen AE, Noviani M, Mills JS, Baker KM, Lin FH, Truskey GA, : Point-of-care seeding of nitinol stents with blood-derived endothelial cells. J Biomed Mater Res B Appl Biomater 104:1658\u20131665, 201610.1002\/jbm.b.3351026340233"},{"key":"b36-focus16507","series-title":"Neurosurgery","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1227\/NEU.0000000000001146","article-title":"Long-term follow-up of in-stent stenosis after Pipeline flow diversion treatment of intracranial aneurysms","volume":"78","author":"John S,","year":"2016","unstructured":"John S, Bain MD, Hui FK, Hussain MS, Masaryk TJ, Rasmussen PA, : Long-term follow-up of in-stent stenosis after Pipeline flow diversion treatment of intracranial aneurysms. Neurosurgery 78:862\u2013867, 20162660028110.1227\/NEU.0000000000001146"},{"key":"b37-focus16507","series-title":"Am J Cardiol","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.1016\/j.amjcard.2008.07.023","article-title":"Comparison of effectiveness of atorvastatin 10 mg versus 80 mg in reducing major cardiovascular events and repeat revascularization in patients with previous percutaneous coronary intervention (post hoc analysis of the Treating to New Targets [TNT] Study)","volume":"102","author":"Johnson C,","year":"2008","unstructured":"Johnson C, Waters DD, DeMicco DA, Breazna A, Bittner V, Greten H, : Comparison of effectiveness of atorvastatin 10 mg versus 80 mg in reducing major cardiovascular events and repeat revascularization in patients with previous percutaneous coronary intervention (post hoc analysis of the Treating to New Targets [TNT] Study). Am J Cardiol 102:1312\u20131317, 200810.1016\/j.amjcard.2008.07.02318993147"},{"key":"b38-focus16507","series-title":"J Thorac Dis","first-page":"E599","article-title":"Mechanism of in-stent restenosis after second-generation drug-eluting stents (DES): is it different from bare-metal stents and first-generation DES?","volume":"7","author":"Kuramitsu S,","year":"2015","unstructured":"Kuramitsu S, Shirai S, Ando K: Mechanism of in-stent restenosis after second-generation drug-eluting stents (DES): is it different from bare-metal stents and first-generation DES?. J Thorac Dis 7:E599\u2013E602, 2015"},{"key":"b39-focus16507","series-title":"J Am Coll Cardiol","doi-asserted-by":"publisher","first-page":"2473","DOI":"10.1016\/j.jacc.2012.09.020","article-title":"A randomized multicenter study comparing a paclitaxel drug-eluting balloon with a paclitaxel-eluting stent in small coronary vessels: the BELLO (Balloon Elution and Late Loss Optimization) study","volume":"60","author":"Latib A,","year":"2012","unstructured":"Latib A, Colombo A, Castriota F, Micari A, Cremonesi A, De Felice F, : A randomized multicenter study comparing a paclitaxel drug-eluting balloon with a paclitaxel-eluting stent in small coronary vessels: the BELLO (Balloon Elution and Late Loss Optimization) study. J Am Coll Cardiol 60:2473\u20132480, 201210.1016\/j.jacc.2012.09.02023158530"},{"key":"b40-focus16507","series-title":"AJNR Am J Neuroradiol","doi-asserted-by":"publisher","first-page":"487","DOI":"10.3174\/ajnr.A4550","article-title":"Posterior inferior cerebellar artery patency after flow-diverting stent treatment","volume":"37","author":"Levitt MR,","year":"2016","unstructured":"Levitt MR, Park MS, Albuquerque FC, Moon K, Kalani MY, McDougall CG: Posterior inferior cerebellar artery patency after flow-diverting stent treatment. AJNR Am J Neuroradiol 37:487\u2013489, 201610.3174\/ajnr.A455026427829"},{"key":"b41-focus16507","series-title":"Cardiovasc Diabetol","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/1475-2840-8-41","article-title":"The role of glucose lowering agents on restenosis after percutaneous coronary intervention in patients with diabetes mellitus.","volume":"8","author":"Lexis CP,","year":"2009","unstructured":"Lexis CP, Rahel BM, Meeder JG, Zijlstra F, van der Horst IC: The role of glucose lowering agents on restenosis after percutaneous coronary intervention in patients with diabetes mellitus.. Cardiovasc Diabetol 8:41, 20091963517010.1186\/1475-2840-8-41"},{"key":"b42-focus16507","series-title":"J Endovasc Ther","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1583\/JEVT-12-3942R.1","article-title":"Drug-eluting balloon angioplasty for carotid in-stent restenosis","volume":"19","author":"Liistro F,","year":"2012","unstructured":"Liistro F, Porto I, Grotti S, Ventoruzzo G, Vergallo R, Bellandi G, : Drug-eluting balloon angioplasty for carotid in-stent restenosis. J Endovasc Ther 19:729\u2013733, 20122321086910.1583\/JEVT-12-3942R.1"},{"key":"b43-focus16507","series-title":"Circulation","doi-asserted-by":"publisher","first-page":"2233","DOI":"10.1161\/01.CIR.0000163561.90680.1C","article-title":"Dual antiplatelet therapy with clopidogrel and aspirin in symptomatic carotid stenosis evaluated using Doppler embolic signal detection: the Clopidogrel and Aspirin for Reduction of Emboli in Symptomatic Carotid Stenosis (CARESS) trial","volume":"111","author":"Markus HS,","year":"2005","unstructured":"Markus HS, Droste DW, Kaps M, Larrue V, Lees KR, Siebler M, : Dual antiplatelet therapy with clopidogrel and aspirin in symptomatic carotid stenosis evaluated using Doppler embolic signal detection: the Clopidogrel and Aspirin for Reduction of Emboli in Symptomatic Carotid Stenosis (CARESS) trial. Circulation 111:2233\u20132240, 20051585160110.1161\/01.CIR.0000163561.90680.1C"},{"key":"b44-focus16507","series-title":"J Neurointerv Surg","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1136\/neurintsurg-2015-012040","article-title":"Pipeline embolization device for the treatment of vertebral artery aneurysms: the fate of covered branch vessels","volume":"8","author":"Mazur MD,","year":"2016","unstructured":"Mazur MD, Kilburg C, Wang V, Taussky P: Pipeline embolization device for the treatment of vertebral artery aneurysms: the fate of covered branch vessels. J Neurointerv Surg 8:1041\u20131047, 20162649104110.1136\/neurintsurg-2015-012040"},{"key":"b45-focus16507","series-title":"J Endovasc Ther","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1583\/JEVT-12-4042R.1","article-title":"Drug-eluting balloon for treatment of in-stent restenosis after carotid artery stenting: preliminary report","volume":"19","author":"Montorsi P,","year":"2012","unstructured":"Montorsi P, Galli S, Ravagnani PM, Trabattoni D, Fabbiocchi F, Lualdi A, : Drug-eluting balloon for treatment of in-stent restenosis after carotid artery stenting: preliminary report. J Endovasc Ther 19:734\u2013742, 20122321087010.1583\/JEVT-12-4042R.1"},{"key":"b46-focus16507","series-title":"Stroke","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1161\/01.STR.15.2.260","article-title":"Vertebral artery stenosis: long-term follow-up","volume":"15","author":"Moufarrij NA,","year":"1984","unstructured":"Moufarrij NA, Little JR, Furlan AJ, Williams G, Marzewski DJ: Vertebral artery stenosis: long-term follow-up. Stroke 15:260\u2013263, 1984670193410.1161\/01.STR.15.2.260"},{"key":"b47-focus16507","series-title":"Circulation","first-page":"e38","article-title":"Heart Disease and Stroke Statistics\u20142016 Update: a report from the American Heart Association","volume":"133","author":"Mozaffarian D,","year":"2016","unstructured":"Mozaffarian D, Benjamin EJ, Go AS, Arnett DK, Blaha MJ, Cushman M, : Heart Disease and Stroke Statistics\u20142016 Update: a report from the American Heart Association. Circulation 133:e38\u2013e360, 2016. (Erratum in Circulation 133: e599, 2016)"},{"key":"b48-focus16507","series-title":"J Invasive Cardiol","first-page":"439","article-title":"Efficacy of cutting balloon angioplasty for in-stent restenosis: an intravascular ultrasound evaluation","volume":"13","author":"Muramatsu T,","year":"2001","unstructured":"Muramatsu T, Tsukahara R, Ho M, Ito Y, Hirano K, Ishimori H, : Efficacy of cutting balloon angioplasty for in-stent restenosis: an intravascular ultrasound evaluation. J Invasive Cardiol 13:439\u2013444, 200111385165"},{"key":"b49-focus16507","series-title":"Int J Cardiol","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.ijcard.2015.01.080","article-title":"A 2-year follow-up of a randomized multicenter study comparing a paclitaxel drug-eluting balloon with a paclitaxel-eluting stent in small coronary vessels the BELLO study","volume":"184","author":"Naganuma T,","year":"2015","unstructured":"Naganuma T, Latib A, Sgueglia GA, Menozzi A, Castriota F, Micari A, : A 2-year follow-up of a randomized multicenter study comparing a paclitaxel drug-eluting balloon with a paclitaxel-eluting stent in small coronary vessels the BELLO study. Int J Cardiol 184:17\u201321, 201510.1016\/j.ijcard.2015.01.08025705005"},{"key":"b50-focus16507","series-title":"AJNR Am J Neuroradiol","doi-asserted-by":"publisher","first-page":"34","DOI":"10.3174\/ajnr.A2421","article-title":"The pipeline embolization device for the intracranial treatment of aneurysms trial","volume":"32","author":"Nelson PK,","year":"2011","unstructured":"Nelson PK, Lylyk P, Szikora I, Wetzel SG, Wanke I, Fiorella D: The pipeline embolization device for the intracranial treatment of aneurysms trial. AJNR Am J Neuroradiol 32:34\u201340, 20112114825610.3174\/ajnr.A2421"},{"key":"b51-focus16507","series-title":"N Engl J Med","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1056\/NEJM199108153250701","article-title":"Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis","volume":"325","author":"North American Symptomatic Carotid Endarterectomy Trial Collaborators","year":"1991","unstructured":"North American Symptomatic Carotid Endarterectomy Trial Collaborators: Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis. N Engl J Med 325:445\u2013453, 199110.1056\/NEJM1991081532507011852179"},{"key":"b52-focus16507","series-title":"Ann Biomed Eng","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1007\/s10439-015-1380-x","article-title":"Coronary stent materials and coatings: a technology and performance update","volume":"44","author":"O'Brien B,","year":"2016","unstructured":"O'Brien B, Zafar H, Ibrahim A, Zafar J, Sharif F: Coronary stent materials and coatings: a technology and performance update. Ann Biomed Eng 44:523\u2013535, 20162613929710.1007\/s10439-015-1380-x"},{"key":"b53-focus16507","series-title":"Circulation","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1161\/CIRCULATIONAHA.110.971606","article-title":"Bioresorbable scaffold: the advent of a new era in percutaneous coronary and peripheral revascularization?","volume":"123","author":"Onuma Y,","year":"2011","unstructured":"Onuma Y, Serruys PW: Bioresorbable scaffold: the advent of a new era in percutaneous coronary and peripheral revascularization?. Circulation 123:779\u2013797, 20112134359410.1161\/CIRCULATIONAHA.110.971606"},{"key":"b54-focus16507","series-title":"Circulation","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1161\/CIRCULATIONAHA.113.001790","article-title":"Pathology of second-generation everolimus-eluting stents versus first-generation sirolimus- and paclitaxel-eluting stents in humans","volume":"129","author":"Otsuka F,","year":"2014","unstructured":"Otsuka F, Vorpahl M, Nakano M, Foerst J, Newell JB, Sakakura K, : Pathology of second-generation everolimus-eluting stents versus first-generation sirolimus- and paclitaxel-eluting stents in humans. Circulation 129:211\u2013223, 20142416306410.1161\/CIRCULATIONAHA.113.001790"},{"key":"b55-focus16507","series-title":"Neurosurgery","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1227\/01.NEU.0000370010.09419.23","article-title":"Vertebral artery origin stents revisited: improved results with paclitaxel-eluting stents","volume":"67","author":"Park MS,","year":"2010","unstructured":"Park MS, Fiorella D, Stiefel MF, Dashti SR, Gonzalez LF, McDougall CG, : Vertebral artery origin stents revisited: improved results with paclitaxel-eluting stents. Neurosurgery 67:41\u201348, 20102056866610.1227\/01.NEU.0000370010.09419.23"},{"key":"b56-focus16507","series-title":"J Endovasc Ther","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1177\/1526602815573498","article-title":"Drug-coated balloon dilation before carotid artery stenting of post-carotid endarterectomy restenosis","volume":"22","author":"Piccoli G,","year":"2015","unstructured":"Piccoli G, Biondi-Zoccai G, Gavrilovic V, Radici V, Cancelli I, Frigatti P, : Drug-coated balloon dilation before carotid artery stenting of post-carotid endarterectomy restenosis. J Endovasc Ther 22:212\u2013216, 20152580936410.1177\/1526602815573498"},{"key":"b57-focus16507","series-title":"Cardiovasc Ther","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1111\/j.1755-5922.2011.00302.x","article-title":"Do statins have a role in reduction\/prevention of post-PCI restenosis?","volume":"31","author":"Prasad K:","year":"2013","unstructured":"Prasad K: Do statins have a role in reduction\/prevention of post-PCI restenosis?. Cardiovasc Ther 31:12\u201326, 20132196767410.1111\/j.1755-5922.2011.00302.x"},{"key":"b58-focus16507","series-title":"Stroke","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1161\/01.STR.26.1.14","article-title":"Race-ethnicity and determinants of intracranial atherosclerotic cerebral infarction. The Northern Manhattan Stroke Study","volume":"26","author":"Sacco RL,","year":"1995","unstructured":"Sacco RL, Kargman DE, Gu Q, Zamanillo MC: Race-ethnicity and determinants of intracranial atherosclerotic cerebral infarction. The Northern Manhattan Stroke Study. Stroke 26:14\u201320, 1995783938810.1161\/01.STR.26.1.14"},{"key":"b59-focus16507","series-title":"N Engl J Med","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1056\/NEJMra051091","article-title":"Coronary-artery stents","volume":"354","author":"Serruys PW,","year":"2006","unstructured":"Serruys PW, Kutryk MJ, Ong AT: Coronary-artery stents. N Engl J Med 354:483\u2013495, 200610.1056\/NEJMra05109116452560"},{"key":"b60-focus16507","series-title":"N Engl J Med","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1056\/NEJM200104123441502","article-title":"Comparison of coronary-artery bypass surgery and stenting for the treatment of multivessel disease","volume":"344","author":"Serruys PW,","year":"2001","unstructured":"Serruys PW, Unger F, Sousa JE, Jatene A, Bonnier HJ, Sch\u00f6nberger JP, : Comparison of coronary-artery bypass surgery and stenting for the treatment of multivessel disease. N Engl J Med 344:1117\u20131124, 200110.1056\/NEJM20010412344150211297702"},{"key":"b61-focus16507","series-title":"J Am Coll Cardiol","doi-asserted-by":"publisher","first-page":"1757","DOI":"10.1016\/j.jacc.2003.04.001","article-title":"The effects of rosiglitazone, a peroxisome proliferator-activated receptor-gamma agonist, on markers of endothelial cell activation, C-reactive protein, and fibrinogen levels in non-diabetic coronary artery disease patients","volume":"42","author":"Sidhu JS,","year":"2003","unstructured":"Sidhu JS, Cowan D, Kaski JC: The effects of rosiglitazone, a peroxisome proliferator-activated receptor-gamma agonist, on markers of endothelial cell activation, C-reactive protein, and fibrinogen levels in non-diabetic coronary artery disease patients. J Am Coll Cardiol 42:1757\u20131763, 200310.1016\/j.jacc.2003.04.00114642684"},{"key":"b62-focus16507","series-title":"Eur Rev Med Pharmacol Sci","first-page":"311","article-title":"Study of a novel coating strategy for coronary stents: evaluation of stainless metallic steel coated with VEGF and anti-CD34 antibody in vitro","volume":"20","author":"Song CL,","year":"2016","unstructured":"Song CL, Li Q, Zhang JC, Wang JP, Xue X, Wang G, : Study of a novel coating strategy for coronary stents: evaluation of stainless metallic steel coated with VEGF and anti-CD34 antibody in vitro. Eur Rev Med Pharmacol Sci 20:311\u2013316, 201626875902"},{"key":"b63-focus16507","series-title":"N Engl J Med","doi-asserted-by":"publisher","first-page":"1946","DOI":"10.1056\/NEJMoa0810116","article-title":"Paclitaxel-eluting stents versus bare-metal stents in acute myocardial infarction","volume":"360","author":"Stone GW,","year":"2009","unstructured":"Stone GW, Lansky AJ, Pocock SJ, Gersh BJ, Dangas G, Wong SC, : Paclitaxel-eluting stents versus bare-metal stents in acute myocardial infarction. N Engl J Med 360:1946\u20131959, 200910.1056\/NEJMoa081011619420364"},{"key":"b64-focus16507","series-title":"J Invasive Cardiol","first-page":"133","article-title":"Cutting balloon angioplasty to treat carotid in-stent restenosis","volume":"16","author":"Tamberella MR,","year":"2004","unstructured":"Tamberella MR, Yadav JS, Bajzer CT, Bhatt DL, Abou-Chebl A: Cutting balloon angioplasty to treat carotid in-stent restenosis. J Invasive Cardiol 16:133\u2013135, 200415152163"},{"key":"b65-focus16507","series-title":"J Neurointerv Surg","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1136\/neurintsurg-2015-011697","article-title":"Drug eluting stents versus bare metal stents for the treatment of extracranial vertebral artery disease: a meta-analysis","volume":"8","author":"Tank VH,","year":"2016","unstructured":"Tank VH, Ghosh R, Gupta V, Sheth N, Gordon S, He W, : Drug eluting stents versus bare metal stents for the treatment of extracranial vertebral artery disease: a meta-analysis. J Neurointerv Surg 8:770\u2013774, 20162618009410.1136\/neurintsurg-2015-011697"},{"key":"b66-focus16507","series-title":"AJNR Am J Neuroradiol","doi-asserted-by":"publisher","first-page":"1653","DOI":"10.3174\/ajnr.A1715","article-title":"Treatment of stenoses of vertebral artery origin using short drug-eluting coronary stents: improved follow-up results","volume":"30","author":"Vajda Z,","year":"2009","unstructured":"Vajda Z, Miloslavski E, G\u00fcthe T, Fischer S, Albes G, Heuschmid A, : Treatment of stenoses of vertebral artery origin using short drug-eluting coronary stents: improved follow-up results. AJNR Am J Neuroradiol 30:1653\u20131656, 200910.3174\/ajnr.A171519729536"},{"key":"b67-focus16507","series-title":"J Vasc Interv Radiol","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.1016\/j.jvir.2010.06.010","article-title":"Therapeutic options for carotid in-stent restenosis: review of the literature","volume":"21","author":"van Haaften AC,","year":"2010","unstructured":"van Haaften AC, Bots ML, Moll FL, de Borst GJ: Therapeutic options for carotid in-stent restenosis: review of the literature. J Vasc Interv Radiol 21:1471\u20131477, 201010.1016\/j.jvir.2010.06.010"},{"key":"b68-focus16507","series-title":"Diagn Interv Radiol","first-page":"345","article-title":"Flow diverter as a rescue therapy for a complicated basilar angioplasty","volume":"19","author":"Velioglu M,","year":"2013","unstructured":"Velioglu M, Ozturk E, Sonmez G, Kendirli T, Mutlu H, Basekim C: Flow diverter as a rescue therapy for a complicated basilar angioplasty. Diagn Interv Radiol 19:345\u2013348, 201323439254"},{"key":"b69-focus16507","series-title":"N Engl J Med","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1056\/NEJMoa040127","article-title":"Protected carotid-artery stenting versus endarterectomy in high-risk patients","volume":"351","author":"Yadav JS,","year":"2004","unstructured":"Yadav JS, Wholey MH, Kuntz RE, Fayad P, Katzen BT, Mishkel GJ, : Protected carotid-artery stenting versus endarterectomy in high-risk patients. N Engl J Med 351:1493\u20131501, 20041547021210.1056\/NEJMoa040127"},{"key":"b70-focus16507","series-title":"JAMA","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1001\/jama.2015.1693","article-title":"Effect of a balloon-expandable intracranial stent vs medical therapy on risk of stroke in patients with symptomatic intracranial stenosis: the VISSIT randomized clinical trial","volume":"313","author":"Zaidat OO,","year":"2015","unstructured":"Zaidat OO, Fitzsimmons BF, Woodward BK, Wang Z, Killer-Oberpfalzer M, Wakhloo A, : Effect of a balloon-expandable intracranial stent vs medical therapy on risk of stroke in patients with symptomatic intracranial stenosis: the VISSIT randomized clinical trial. JAMA 313:1240\u20131248, 201510.1001\/jama.2015.169325803346"},{"key":"b71-focus16507","series-title":"J Mater Sci Mater Med","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1007\/s10856-016-5693-6","article-title":"Constructing bio-layer of heparin and type IV collagen on titanium surface for improving its endothelialization and blood compatibility.","volume":"27","author":"Zhang K,","year":"2016","unstructured":"Zhang K, Chen JY, Qin W, Li JA, Guan FX, Huang N: Constructing bio-layer of heparin and type IV collagen on titanium surface for improving its endothelialization and blood compatibility.. J Mater Sci Mater Med 27:81, 201610.1007\/s10856-016-5693-626936367"}],"container-title":["Neurosurgical Focus"],"original-title":[],"link":[{"URL":"https:\/\/thejns.org\/view\/journals\/neurosurg-focus\/42\/4\/article-pE11.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/thejns.org\/downloadpdf\/journals\/neurosurg-focus\/42\/4\/article-pE11.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/thejns.org\/downloadpdf\/journals\/neurosurg-focus\/42\/4\/article-pE11.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T08:19:10Z","timestamp":1780733950000},"score":1,"resource":{"primary":{"URL":"https:\/\/thejns.org\/view\/journals\/neurosurg-focus\/42\/4\/article-pE11.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4]]},"references-count":142,"journal-issue":{"issue":"4"},"URL":"https:\/\/doi.org\/10.3171\/2017.1.focus16507","relation":{},"ISSN":["1092-0684"],"issn-type":[{"value":"1092-0684","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,4]]}}}